Intervention

EPI-326

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 1 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting1

Common conditions15

Lead sponsors shown1

Clinical trials

1 shown

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCNCT07462377 · 2026-03-31

RECRUITING

Common conditions

EGFR1 Epidermal Growth Factor1 Epidermal Growth Factor Receptor1 Epidermal Growth Factor Receptor Gene Mutation1 Head and Neck1 Head and Neck Cancer1 Head and Neck Cancers1 Head and Neck Squamous Cell Cancer1 Head and Neck Squamous Cell Carcinoma1 Head and Neck Squamous Cell Carcinoma HNSCC1 HNSCC1 Non Small Cell1 Non Small Cell Lung1 Non Small Cell Lung Cancer1 NSCLC (Non-small Cell Lung Cancer)1

Leading sponsors

EpiBiologics 1

Trial status mix

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.